Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu, et al.
Science Immunology (2022) Vol. 7, Iss. 72
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-Immunotherapy
Wenhao Shen, Pei Pei, Chonghai Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23998-24011
Closed Access | Times Cited: 96
Biomarker-driven molecular imaging probes in radiotherapy
Haonan Li, Qiyong Gong, Kui Luo
Theranostics (2024) Vol. 14, Iss. 10, pp. 4127-4146
Open Access | Times Cited: 78
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 69
The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 55
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
Zhuangzhuang Zheng, Jing Su, Xueying Bao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Oxygen‐driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy
Pei Pei, Yuhong Wang, Wenhao Shen, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 29
A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance
Yi Lei, Xin Jiang, Zaigang Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 27
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 45
The CD47-SIRPα axis is a promising target for cancer immunotherapies
Hao Yu, Xinxuan Zhou, Yiling Li, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110255-110255
Closed Access | Times Cited: 32
CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
Qi Lv, Yishu Zhang, Wenxue Gao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107126-107126
Open Access | Times Cited: 14
Intracellular Magnetic Hyperthermia Enables Concurrent Down-Regulation of CD47 and SIRPα To Potentiate Antitumor Immunity
Siyao Wang, Wangbo Jiao, Bin Yan, et al.
Nano Letters (2024) Vol. 24, Iss. 9, pp. 2894-2903
Closed Access | Times Cited: 9
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
Xiaofeng Dai, Zhipeng Wu, Ruiwen Ruan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma
Hidekazu Oyoshi, Junyan Du, Shunsuke A. Sakai, et al.
Science Advances (2023) Vol. 9, Iss. 50
Open Access | Times Cited: 17
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade
Cassia Wang, Lee Chen, Doris Fu, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 4, pp. 333-349
Open Access | Times Cited: 8
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice
Elselien Frijlink, Douwe M. T. Bosma, Julia Busselaar, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 7
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
Chung‐Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e922-e931
Open Access | Times Cited: 6
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data
Ji Y. Son, Cheng‐En Hsieh, Heather Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy
Charleen M. L. Chan Wah Hak, Antonio Rullan, Emmanuel C. Patin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
cGAS-STING signaling pathway in intestinal homeostasis and diseases
Yuchen Yang, Li Wang, Ivonne Peugnet-González, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy
Sirimuvva Tadepalli, Derek R. Clements, Sanjana Saravanan, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 13
Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis
Wenyao Zhen, Yingjie Fan, Tomas Germanas, et al.
Advanced Materials (2024)
Open Access | Times Cited: 5
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Leonie M. Behrens, Timo K. van den Berg, Marjolein van Egmond
Cancers (2022) Vol. 14, Iss. 14, pp. 3366-3366
Open Access | Times Cited: 21
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Zi-Han Ye, Wei-Bang Yu, Mu‐Yang Huang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1467-1487
Open Access | Times Cited: 19
Targeting phagocytosis to enhance antitumor immunity
Kristin Huntoon, DaeYong Lee, Shiyan Dong, et al.
Trends in cancer (2023) Vol. 9, Iss. 8, pp. 650-665
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top